Life Sciences Tools & Services Companies By Net Asset

Net Asset
Net AssetEfficiencyMarket RiskExp Return
1TMO Thermo Fisher Scientific
97.32 B
(0.03)
 1.57 
(0.05)
2IQV IQVIA Holdings
26.9 B
(0.10)
 1.61 
(0.16)
3ICLR ICON PLC
16.88 B
(0.11)
 2.07 
(0.24)
4RVTY Revvity
12.39 B
(0.03)
 2.01 
(0.07)
5AVTR Avantor
12.11 B
(0.14)
 2.75 
(0.40)
6A Agilent Technologies
11.85 B
(0.13)
 1.64 
(0.22)
7BIO-B Bio Rad Laboratories
9.36 B
(0.24)
 4.12 
(0.98)
8BIO Bio Rad Laboratories
9.36 B
(0.19)
 2.36 
(0.45)
9CRL Charles River Laboratories
7.53 B
(0.10)
 2.35 
(0.24)
10ILMN Illumina
6.3 B
(0.29)
 2.74 
(0.80)
11BRKR Bruker
5.81 B
(0.19)
 2.59 
(0.50)
12QGEN Qiagen NV
5.69 B
(0.12)
 1.51 
(0.18)
13WAT Waters
4.55 B
(0.01)
 1.84 
(0.02)
14FTRE Fortrea Holdings
3.58 B
(0.29)
 4.29 
(1.25)
15CDT Conduit Pharmaceuticals
3.26 B
(0.14)
 16.66 
(2.30)
16MTD Mettler Toledo International
3.24 B
(0.03)
 1.60 
(0.05)
17SHC Sotera Health Co
3.07 B
(0.08)
 2.20 
(0.18)
18RGEN Repligen
2.83 B
(0.02)
 3.17 
(0.07)
19TECH Bio Techne Corp
2.7 B
(0.14)
 2.18 
(0.31)
20MEDP Medpace Holdings
2.1 B
(0.03)
 1.98 
(0.06)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund. Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.